Detail akcie Novozymes online

Business Summary: Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Novozymes A/S revenues increased 2% to DKR17.9B. Net income decreased 18% to DKR3.02B. Revenues reflect Bioenergy segment increase of 19% to DKR4.45B, Household Care segment increase of 2% to DKR5.11B, Latin America segment increase of 11% to DKR2.3B, North America segment increase of 4% to DKR6.06B. Net income was offset by Special items increase from DKR68M to DKR576M (expense).